546 related articles for article (PubMed ID: 17662776)
1. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
2. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
[TBL] [Abstract][Full Text] [Related]
3. Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.
Pedrazzani C; deManzoni G; Marrelli D; Giacopuzzi S; Corso G; Bernini M; Roviello F
Ann Surg Oncol; 2007 Feb; 14(2):299-305. PubMed ID: 17146743
[TBL] [Abstract][Full Text] [Related]
4. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
5. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
6. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
[TBL] [Abstract][Full Text] [Related]
7. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
9. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
[TBL] [Abstract][Full Text] [Related]
10. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
[TBL] [Abstract][Full Text] [Related]
15. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of lymph node metastasis in Siewert type II adenocarcinoma of the gastroesophageal junction].
Li SM; Li ZY; Ji X
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):288-91. PubMed ID: 23985258
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the esophagogastric junction in Japan.
Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
[TBL] [Abstract][Full Text] [Related]
19. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
Mönig SP; Schröder W; Beckurts KT; Hölscher AH
Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]